Lora Rose Weiselberg
Impact in
Papers in
-
- Acute Myeloid Leukemia Research 7
- Oncology 6
- Cancer Treatment and Pharmacology 3
- Co-authors
- Willet F. Whitmore (3 shared papers)Michael J. Morse (3 shared papers)Harry W. Herr (3 shared papers)Nancy L. Geller (3 shared papers)Howard I. Scher (3 shared papers)Alan Yagoda (3 shared papers)Cora Nanette Sternberg (3 shared papers)Pramod C. Sogani (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer (2 papers)The Journal of Urology (2 papers)American Journal of Clinical Pathology (1 paper)
- Partner nations
- United States
In The Last Decade
Lora Rose Weiselberg
30 papers receiving 2.4k citations
Lora Rose Weiselberg's Hit Papers
Peers
Comparison fields: 5 of 82
- Surgery 1.4k
- Genetics 178
- Geriatrics and Gerontology 46
- Pulmonary and Respiratory Medicine 392
- Oncology 254
Countries citing papers authored by Lora Rose Weiselberg
This map shows the geographic impact of Lora Rose Weiselberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lora Rose Weiselberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lora Rose Weiselberg more than expected).
Fields of papers citing papers by Lora Rose Weiselberg
This network shows the impact of papers produced by Lora Rose Weiselberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lora Rose Weiselberg. The network helps show where Lora Rose Weiselberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Lora Rose Weiselberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse Hit paper breakdown → | 1989 | 571 |
| 2 | Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium Hit paper breakdown → | 1985 | 538 |
| 3 | M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium Hit paper breakdown → | 1988 | 522 |
| 4 | Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study Hit paper breakdown → | 2017 | 313 |
| 5 | 1989 | 255 | |
| 6 | 2021 | 52 | |
| 7 | 1999 | 48 | |
| 8 | 1992 | 37 | |
| 9 | Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hours. | 1988 | 33 |
| 10 | 2021 | 27 | |
| 11 | Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study. | 1991 | 22 |
| 12 | Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma. | 1983 | 20 |
| 13 | 1984 | 19 | |
| 14 | 1991 | 19 | |
| 15 | Pharmacokinetics of low-dose 1-beta-D-arabinofuranosylcytosine given by continuous intravenous infusion over twenty-one days. | 1985 | 18 |
| 16 | Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma. | 1982 | 16 |
| 17 | 1983 | 16 | |
| 18 | Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma. | 1985 | 11 |
| 19 | 1999 | 11 | |
| 20 | Phase I trial of vinzolidine. | 1984 | 9 |
About Lora Rose Weiselberg
Lora Rose Weiselberg is a scholar working on Hematology, Oncology, Pharmacology, Geriatrics and Gerontology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Alkaloids: synthesis and pharmacology (2 papers), Frailty in Older Adults (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Surgery (1.4k citations), Genetics (178 citations), Geriatrics and Gerontology (46 citations), Pulmonary and Respiratory Medicine (392 citations) and Oncology (254 citations). Lora Rose Weiselberg has collaborated with scholars based in United States. Frequent co-authors include Willet F. Whitmore, Michael J. Morse, Harry W. Herr, Nancy L. Geller, Howard I. Scher, Alan Yagoda, Cora Nanette Sternberg, Pramod C. Sogani, Robin C. Watson and Phyllis S. Hollander. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer, The Journal of Urology and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.